Achieving market access and setting the right price demands a comprehensive strategy (see also our services for evidence exploration, competitor analysis and health economic evaluation/modelling). Our consultants bring invaluable insights and a wealth of experience to navigate the complex landscape of the pharmaceutical and health technology market.

SOLUTIONS WE OFFER:

Market Access Feasibility Assessments: We assess the feasibility of your product’s market access, identifying potential barriers and opportunities. This is a pivotal first step before developing a PBAC submission or MSAC submission.

Pricing Strategy: Our experts craft pricing strategies that align with the value your product offers, ensuring competitive pricing while maximising returns.

Strategic Reviews of PBAC and MSAC Outcomes: We critically review PBAC and MSAC outcomes to refine your strategy and improve the chances of success.

Risk Share Arrangements: We design risk-sharing models to address uncertainties by the payer.

Clinical Evaluation: Our team conducts an exhaustive clinical appraisal, leveraging both clinical trial data and real-world study data. We leave no stone unturned in dissecting the evidence, ensuring that your intervention’s clinical efficacy and safety are presented with precision and scientific rigor.

---

---